Business Description
InhaleRx Ltd
ISIN : AU0000179475
Description
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.04 | |||||
| Equity-to-Asset | -0.09 | |||||
| Debt-to-Equity | -6.14 | |||||
| Debt-to-EBITDA | -0.46 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12.6 | |||||
| 3-Year EPS without NRI Growth Rate | 12.6 | |||||
| 3-Year FCF Growth Rate | 3.1 | |||||
| 3-Year Book Growth Rate | -26.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.41 | |||||
| 9-Day RSI | 57.85 | |||||
| 14-Day RSI | 54.9 | |||||
| 6-1 Month Momentum % | -45 | |||||
| 12-1 Month Momentum % | -43.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.92 | |||||
| Quick Ratio | 0.92 | |||||
| Cash Ratio | 0.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.1 | |||||
| Shareholder Yield % | -8.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -179.53 | |||||
| ROA % | -69.26 | |||||
| ROIC % | -433.09 | |||||
| 3-Year ROIIC % | -371.58 | |||||
| ROC (Joel Greenblatt) % | -319.27 | |||||
| ROCE % | -164.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 7.5 | |||||
| EV-to-EBIT | -9.08 | |||||
| EV-to-EBITDA | -9.08 | |||||
| EV-to-FCF | -16.13 | |||||
| Earnings Yield (Greenblatt) % | -11.01 | |||||
| FCF Yield % | -6.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InhaleRx Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.004 | ||
| Beta | 0.04 | ||
| Volatility % | 129.52 | ||
| 14-Day RSI | 54.9 | ||
| 14-Day ATR (A$) | 0.001752 | ||
| 20-Day SMA (A$) | 0.028275 | ||
| 12-1 Month Momentum % | -43.59 | ||
| 52-Week Range (A$) | 0.02 - 0.05 | ||
| Shares Outstanding (Mil) | 211.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InhaleRx Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InhaleRx Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
InhaleRx Ltd Frequently Asked Questions
What is InhaleRx Ltd(ASX:IRX)'s stock price today?
The current price of ASX:IRX is A$0.03. The 52 week high of ASX:IRX is A$0.05 and 52 week low is A$0.02.
When is next earnings date of InhaleRx Ltd(ASX:IRX)?
The next earnings date of InhaleRx Ltd(ASX:IRX) is .
Does InhaleRx Ltd(ASX:IRX) pay dividends? If so, how much?
InhaleRx Ltd(ASX:IRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers